Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.

Courtesy Lowenthal For decades, people suffering life-threatening allergic reactions had to quickly and correctly give ...

The Joico Humidity Blocker+ Protective Finishing Spray is a smoothing, shine-inducing styling mist designed for all hair types. Similar to hairspray in consistency and application method ...

PALM BEACH GARDENS, Fla. — Ossamene Clervoyant, a security guard at the Palm Beach Gardens Department of Motor Vehicles, was arrested on May 5 following a violent altercation with a man ...

ARS Pharmaceuticals (NASDAQ:SPRY) has signed a four-year agreement with ALK-Abelló A/S to co-promote neffy, its epinephrine ...